These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 26409505)

  • 1. What immunosuppression should be used for old-to-old recipients?
    Le Meur Y
    Transplant Rev (Orlando); 2015 Oct; 29(4):231-6. PubMed ID: 26409505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppression of the elderly kidney transplant recipient.
    Danovitch GM; Gill J; Bunnapradist S
    Transplantation; 2007 Aug; 84(3):285-91. PubMed ID: 17700150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological characteristics of the elderly allograft recipient.
    Klinger M; Banasik M
    Transplant Rev (Orlando); 2015 Oct; 29(4):219-23. PubMed ID: 26409504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Rationale for Age-Adapted Immunosuppression in Organ Transplantation.
    Krenzien F; ElKhal A; Quante M; Rodriguez Cetina Biefer H; Hirofumi U; Gabardi S; Tullius SG
    Transplantation; 2015 Nov; 99(11):2258-68. PubMed ID: 26244716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What has changed in more than 40 years of activity and 3000 kidney transplants at Policlinico University Hospital, Milan.
    Berardinelli L; Raiteri M; Beretta C; Pasciucco A; Giussani A; Carini M; Marenghi C; Rossetti A; Piccolo G
    Clin Transpl; 2011; ():99-110. PubMed ID: 22755406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Need for optimized immunosuppression in elderly kidney transplant recipients.
    Lehner LJ; Staeck O; Halleck F; Liefeldt L; Bamoulid J; Budde K
    Transplant Rev (Orlando); 2015 Oct; 29(4):237-9. PubMed ID: 26411381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome of intensive initial immunosuppression protocol in pediatric deceased donor renal transplantation.
    Olaitan OK; Zimmermann JA; Shields WP; Rodriguez-Navas G; Awan A; Mohan P; Little DM; Hickey DP
    Pediatr Transplant; 2010 Feb; 14(1):87-92. PubMed ID: 19309452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
    Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
    Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Kidney transplantation: more kidneys from living donors, individualised immunosuppression and better results].
    van Gelder T; Hesselink DA; Roodnat JI; Ijzermans JN; Weimar W
    Ned Tijdschr Geneeskd; 2003 May; 147(20):955-9. PubMed ID: 12784528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [What is the best immunosuppression for the elderly kidney transplantation patient?].
    Ladrière M
    Nephrol Ther; 2008 Oct; 4 Suppl 3():S179-83. PubMed ID: 19000883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction therapy in renal transplant recipients: a review.
    Laftavi MR; Sharma R; Feng L; Said M; Pankewycz O
    Immunol Invest; 2014; 43(8):790-806. PubMed ID: 25296234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transplant immunology and immunosuppression: core curriculum 2015.
    Hricik DE
    Am J Kidney Dis; 2015 Jun; 65(6):956-66. PubMed ID: 25911314
    [No Abstract]   [Full Text] [Related]  

  • 13. The ABCs of Immunosuppression: A Primer for Primary Care Physicians.
    Malat G; Culkin C
    Med Clin North Am; 2016 May; 100(3):505-18. PubMed ID: 27095642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kidney transplantation in the older adult.
    Knoll GA
    Am J Kidney Dis; 2013 May; 61(5):790-7. PubMed ID: 23261121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The UNOS Scientific Renal Transplant Registry--ten years of kidney transplants.
    Cecka JM
    Clin Transpl; 1997; ():1-14. PubMed ID: 9919387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should aging recipients of kidney grafts receive less immunosuppression?
    Palomar R; Ruiz JC; Escallada R; Rodrigo E; Cotorruelo J; Heras M; Zubimendi JA; Arias M
    Transplant Proc; 1999 Sep; 31(6):2277-8. PubMed ID: 10500575
    [No Abstract]   [Full Text] [Related]  

  • 17. Reconsidering the detection of tolerance to individualize immunosuppression minimization and to improve long-term kidney graft outcomes.
    Baron D; Giral M; Brouard S
    Transpl Int; 2015 Aug; 28(8):938-59. PubMed ID: 25851900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. OKT3 prophylaxis in kidney transplant recipients: drug monitoring by flow cytometry.
    Cinti P; Cocciolo P; Evangelista B; Orlandini AM; Bruzzone P; Renna Molajoni E; Cortesini R
    Transplant Proc; 1996 Dec; 28(6):3214-6. PubMed ID: 8962245
    [No Abstract]   [Full Text] [Related]  

  • 19. Modifications of immune regulations with increasing donor & recipient age.
    Pascher A; Pratschke J; Neuhaus P; Tullius SG
    Ann Transplant; 2004; 9(1):72-3. PubMed ID: 15478897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The mechanisms of chronic kidney damage in renal transplant and their possible reversibility].
    Schena FP; Maiorano A; Rossini M
    G Ital Nefrol; 2008; 25 Suppl 44():S11-4. PubMed ID: 19048580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.